Neurocrine Biosciences, Inc. (NBIX): Price and Financial Metrics

Neurocrine Biosciences, Inc. (NBIX): $136.10

0.65 (+0.48%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

A

Add NBIX to Watchlist
Sign Up

NBIX Price/Volume Stats

Current price $136.10 52-week high $148.37
Prev. close $135.45 52-week low $93.02
Day low $134.45 Volume 184,711
Day high $136.87 Avg. volume 814,873
50-day MA $137.43 Dividend yield N/A
200-day MA $127.56 Market Cap 13.70B

NBIX Stock Price Chart Interactive Chart >


Neurocrine Biosciences, Inc. (NBIX) Company Bio


Neurocrine Biosciences discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company was founded in 1992 and is based in San Diego, California.


NBIX Latest News Stream


Event/Time News Detail
Loading, please wait...

NBIX Latest Social Stream


Loading social stream, please wait...

View Full NBIX Social Stream

Latest NBIX News From Around the Web

Below are the latest news stories about NEUROCRINE BIOSCIENCES INC that investors may wish to consider to help them evaluate NBIX as an investment opportunity.

3 Stocks at the Forefront of Medical Innovation

Boring businesses and industries typically show new faces when technology comes around; today, these biotech stocks are leading the way.

Gabriel Osorio-Mazzilli on InvestorPlace | December 26, 2023

13 High Growth Healthcare Stocks to Buy

In this article, we will take a look at 13 high growth healthcare stocks to buy. To skip our analysis of the recent market activity, you can go directly to see the 5 Best High Growth Healthcare Stocks to Buy. For the purpose of this article, we have defined high growth stocks as stocks that […]

Yahoo | December 26, 2023

Neurocrine (NBIX) Soars 6.0%: Is Further Upside Left in the Stock?

Neurocrine (NBIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Yahoo | December 26, 2023

Neurocrine Biosciences' (NASDAQ:NBIX) five-year earnings growth trails the 12% YoY shareholder returns

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...

Yahoo | December 25, 2023

Here’s Why Neurocrine Biosciences (NBIX) Rose in Q3

Harding Loevner, an asset management company, released its “Global Small Companies Equity Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. Global small caps fell sharply in the third quarter. Japan was the weakest region, although returns in healthcare were good and industrials detracted. The strategy returned -5.36% (net) compared to […]

Yahoo | December 20, 2023

Read More 'NBIX' Stories Here

NBIX Price Returns

1-mo -4.35%
3-mo -3.39%
6-mo 13.12%
1-year 39.45%
3-year 35.40%
5-year 59.33%
YTD 3.29%
2023 10.31%
2022 40.24%
2021 -11.14%
2020 -10.83%
2019 50.53%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!